Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies

Gilbert H.L. Tang; Amit Hooda; Ming yu (Anthony) Chuang; Syed Zaid; Hasan A. Ahmad; Joshua B. Goldberg; Samin K. Sharma; Annapoorna S. Kini; John G. Webb; Janarthanan Sathananthan

doi:10.1016/j.jcin.2021.11.032

Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies

Gilbert H.L. Tang, Amit Hooda, Ming yu (Anthony) Chuang, Syed Zaid, Hasan A. Ahmad, Joshua B. Goldberg, Samin K. Sharma, Annapoorna S. Kini, John G. Webb, Janarthanan Sathananthan

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	463-466
Number of pages	4
Journal	JACC: Cardiovascular Interventions
Volume	15
Issue number	4
DOIs	https://doi.org/10.1016/j.jcin.2021.11.032
State	Published - 28 Feb 2022

Access to Document

10.1016/j.jcin.2021.11.032

Cite this

@article{68db5017fb444175a2d59dde590cdc1e,

title = "Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies",

author = "Tang, {Gilbert H.L.} and Amit Hooda and Chuang, {Ming yu (Anthony)} and Syed Zaid and Ahmad, {Hasan A.} and Goldberg, {Joshua B.} and Sharma, {Samin K.} and Kini, {Annapoorna S.} and Webb, {John G.} and Janarthanan Sathananthan",

note = "Funding Information: Dr Tang is a physician proctor for Medtronic; is a consultant for Medtronic, Abbott Structural Heart, and NeoChord; and is a physician advisory board member for Abbott and JenaValve. Dr Sharma has received honoraria as a Speakers Bureau member from Abbott Vascular, Boston Scientific, and Cardiovascular Systems. Dr Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. Dr Sathananthan is a consultant to Edwards Lifesciences, Medtronic, and Boston Scientific; has received speaker fees from New Valve Technologies; and has received research funding from Medtronic and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank Drs Sahil Khera, Parasuram Krishnamoorthy, Stamatios Lerakis, Malcolm Anastasius, Mariama Akodad, David A. Wood, Jonathon A. Leipsic, Philipp Blanke, and George D. Dangas for their contributions to this study. ",

year = "2022",

month = feb,

day = "28",

doi = "10.1016/j.jcin.2021.11.032",

language = "English",

volume = "15",

pages = "463--466",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies

AU - Tang, Gilbert H.L.

AU - Hooda, Amit

AU - Chuang, Ming yu (Anthony)

AU - Zaid, Syed

AU - Ahmad, Hasan A.

AU - Goldberg, Joshua B.

AU - Sharma, Samin K.

AU - Kini, Annapoorna S.

AU - Webb, John G.

AU - Sathananthan, Janarthanan

N1 - Funding Information: Dr Tang is a physician proctor for Medtronic; is a consultant for Medtronic, Abbott Structural Heart, and NeoChord; and is a physician advisory board member for Abbott and JenaValve. Dr Sharma has received honoraria as a Speakers Bureau member from Abbott Vascular, Boston Scientific, and Cardiovascular Systems. Dr Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. Dr Sathananthan is a consultant to Edwards Lifesciences, Medtronic, and Boston Scientific; has received speaker fees from New Valve Technologies; and has received research funding from Medtronic and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank Drs Sahil Khera, Parasuram Krishnamoorthy, Stamatios Lerakis, Malcolm Anastasius, Mariama Akodad, David A. Wood, Jonathon A. Leipsic, Philipp Blanke, and George D. Dangas for their contributions to this study.

PY - 2022/2/28

Y1 - 2022/2/28

UR - http://www.scopus.com/inward/record.url?scp=85124289078&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2021.11.032

DO - 10.1016/j.jcin.2021.11.032

M3 - Letter

C2 - 35210055

AN - SCOPUS:85124289078

SN - 1936-8798

VL - 15

SP - 463

EP - 466

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 4

ER -